MODIFICATION
A -- PREVENT Cancer Preclinical Drug Development Program - Amendment 2
- Notice Date
- 6/1/2018
- Notice Type
- Modification/Amendment
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions-Treatment and Support Branch, Bldg 244, Room 112, Frederick, Maryland, 21702
- ZIP Code
- 21702
- Solicitation Number
- N01CN77019-18
- Archive Date
- 7/6/2018
- Point of Contact
- Nicole Belanger, Phone: 3016248754, Mandie S. White, Phone: 301-624-8756
- E-Mail Address
-
belangern@mail.nih.gov, whitems@mail.nih.gov
(belangern@mail.nih.gov, whitems@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Amendment Two which clarifies dates and answers offerors' questions
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF2/N01CN77019-18/listing.html)
- Record
- SN04941149-W 20180603/180601230828-5ef3dda375c87b1f3960343722c61b4c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |